Ballantyne Jane C
From the Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, Washington.
Anesth Analg. 2017 Nov;125(5):1769-1778. doi: 10.1213/ANE.0000000000002500.
An overreliance on opioids has impacted all types of pain management, making it undoubtedly a root cause of the "epidemic" of prescription opioid abuse in the United States. Yet, an examination of the statistics that led the US Centers for Disease Control and Prevention to declare that prescription opioid abuse had reached epidemic levels shows that the abuse occurrences and deaths are arising outside the hospital or hospice setting, which strongly implicates the outpatient use of opioids to treat chronic pain. Such abuse and related deaths are occurring in chronic pain patients themselves and also through diversion. Overprescribing to outpatients has afforded distressed and vulnerable individuals access to these highly addictive drugs. The focus of this article is on what we have learned since opioid treatment of chronic pain was first popularized at the end of the 20th century and how this new information can guide chronic pain management in the future.
对阿片类药物的过度依赖已经影响了各类疼痛管理,这无疑是美国处方阿片类药物滥用“流行”的一个根本原因。然而,审视那些促使美国疾病控制与预防中心宣布处方阿片类药物滥用已达到流行程度的统计数据会发现,滥用事件和死亡发生在医院或临终关怀机构之外,这有力地表明门诊使用阿片类药物治疗慢性疼痛存在问题。此类滥用及相关死亡不仅发生在慢性疼痛患者自身身上,还通过药物转移的方式出现。对门诊患者的过度开药让痛苦且脆弱的个体有机会接触到这些极易成瘾的药物。本文的重点是自20世纪末阿片类药物治疗慢性疼痛首次普及以来我们所学到的知识,以及这些新信息如何能在未来指导慢性疼痛管理。